OSLO, NORWAY: Nordic Nanovector ASA (OSE: NANOV) announced the appointment of Dr Sandra Jonsson, PhD, MBA as Chief Operating Officer. Dr Sandra Jonsson will start on 10 January 2022 and takes over from Marco Renoldi, MD, who is retiring from the role but will remain as a consultant to the company. Dr Sandra Jonsson is…
All posts tagged Nordic Nanovector
Nordic Nanovector enters research collaboration with University of Pennsylvania
OSLO, NORWAY: Nordic Nanovector ASA has entered into a research collaboration with the University of Pennsylvania to generate a CD37-targeting CAR-T cell approach as a potential treatment for patients with B-cell malignancies. The collaboration aims to combine Nordic Nanovector’s expertise around CD37, a protein present on the surface of B-cell tumour cells, with the world-class…
Nordic Nanovector shortens its executive management team
OSLO: Nordic Nanovector ASA has announced changes to its Executive Management Team. As a result of the cost-saving initiatives announced on 2 April 2020, the Board of Directors of Nordic Nanovector has restructured the senior management team. The restructuring has resulted in the number of executives being reduced from nine to seven. Malene Brondberg, Vice…